School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
Background: Antenatal magnesium sulphate (MgSO<sub>4</sub>) therapy given to women at risk of preterm birth reduced the risk of cerebral palsy in early childhood. However, its effect on longer-term neurological outcomes remains uncertain. This study aimed to assess the effects of antenat...
Main Authors: | Akira Kobayashi, Masato Ito, Erika Ota, Fumihiko Namba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/10/8/1324 |
Similar Items
-
Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU
by: Mariam Ayed, et al.
Published: (2022-06-01) -
Antenatal Magnesium Sulfate for Neuroprotective Effects In Preterm Infants
by: Young lim Oh
Published: (2014-12-01) -
Fetomaternal outcome in patients with early preterm labour following administration of magnesium sulphate - a hospital based prospective study
by: Robin Medhi, et al.
Published: (2023-08-01) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
by: Clément Chollat, et al.
Published: (2017-09-01) -
Antenatal magnesium sulfate and intestinal morbidities in preterm infants with extremely low gestational age
by: Seh Hyun Kim, et al.
Published: (2021-03-01)